Carl Zeiss Meditec AG

XTRA:AFX Stock Report

Market Cap: €5.3b

Carl Zeiss Meditec Balance Sheet Health

Financial Health criteria checks 5/6

Carl Zeiss Meditec has a total shareholder equity of €2.1B and total debt of €448.0M, which brings its debt-to-equity ratio to 21.4%. Its total assets and total liabilities are €3.5B and €1.4B respectively. Carl Zeiss Meditec's EBIT is €177.9M making its interest coverage ratio 8.8. It has cash and short-term investments of €26.6M.

Key information

21.43%

Debt to equity ratio

€447.96m

Debt

Interest coverage ratio8.8x
Cash€26.55m
Equity€2.09b
Total liabilities€1.38b
Total assets€3.47b

Recent financial health updates

These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Mar 03
These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Recent updates

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 19
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

May 16
Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Apr 28
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Mar 23
Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

Mar 20
Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

Mar 15
After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Mar 03
These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

Feb 10
Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Jan 10
More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?

Dec 28
Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?
author-image

AI-Powered Innovations Like KINEVO 900 S And VISUMAX 800 Set To Drive Revenue Growth

New product pipeline and integration of DORC expected to drive revenue and enhance net margins with innovative AI medical solutions.

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Dec 04
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Nov 19
Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Sep 19
Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Aug 23
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26
Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Financial Position Analysis

Short Term Liabilities: AFX's short term assets (€1.3B) exceed its short term liabilities (€628.5M).

Long Term Liabilities: AFX's short term assets (€1.3B) exceed its long term liabilities (€756.0M).

Debt to Equity History and Analysis

Debt Level: AFX's net debt to equity ratio (20.2%) is considered satisfactory.

Reducing Debt: AFX's debt to equity ratio has increased from 0% to 21.4% over the past 5 years.

Debt Coverage: AFX's debt is well covered by operating cash flow (43.7%).

Interest Coverage: AFX's interest payments on its debt are well covered by EBIT (8.8x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 23:57
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Carl Zeiss Meditec AG is covered by 31 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Scott BardoBerenberg
Julien OuaddourBofA Global Research